Landscape Capital Management’s Phoenix Biotech Acquisition Corp. Unit PBAXU Stock Holding History

Landscape Capital Management’s Portfolio PBAXU Stock Details PBAXU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,641	Closed	-$168K	–	990
2022 Q3	$168K	Buy	16,641 +500	+3%	+$5.05K	0.02%	710
2022 Q2	$163K	Hold	16,141	–	–	0.02%	689
2022 Q1	$162K	Hold	16,141	–	–	0.02%	701
2021 Q4	$163K	Buy	+16,141	New	+$163K	0.02%	613

Other funds holding PBAXU

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Landscape Capital Management's PBAXU Position: Q4 2022 in Review

Landscape Capital Management sold out of Phoenix Biotech Acquisition Corp. Unit (PBAXU) in Q4 2022, closing a stake of 16,641 shares — an estimated $168K sold.

Landscape Capital Management first reported a position in PBAXU in Q4 2021 and held it in 4 quarters. The position peaked at $168K in Q3 2022. 3 funds tracked by Wall St. Rank hold PBAXU as of Q4 2022.

Landscape Capital Management reported no remaining Phoenix Biotech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Landscape Capital Management sold 16,641 Phoenix Biotech Acquisition Corp. Unit shares in Q4 2022, an estimated $168K.
Landscape Capital Management first reported a position in Phoenix Biotech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
Landscape Capital Management's Phoenix Biotech Acquisition Corp. Unit position peaked at $168K in Q3 2022.
3 funds tracked by Wall St. Rank held Phoenix Biotech Acquisition Corp. Unit as of Q4 2022.

Based on Landscape Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.